Impaired nuclear translocation of glucocorticoid receptors: Novel findings from psoriatic epidermal keratinocytes

Cellular and Molecular Life Sciences

Volumn 70, Issue 12, 2013, Pages 2205-2220

  Man, Xiao Yong ^a   Li, Wei ^a   Chen, Jia Qi ^a   Zhou, Jiong ^a   Landeck, Lilla ^b   Zhang, Kai Hong ^c   Mu, Zhen ^c   Li, Chun Ming ^a   Cai, Sui Qing ^a   Zheng, Min ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Glucocorticoid receptor; Keratinocyte; Nuclear translocation; Psoriasis

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; PROTEIN P53; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VINCRISTINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DISEASE EXACERBATION; DISEASE MODEL; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOLOCALIZATION; IN VIVO STUDY; KERATINOCYTE; MALE; MICROTUBULE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; PSORIASIS;

ACTIVE TRANSPORT, CELL NUCLEUS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CYTOPLASM; DEXAMETHASONE; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDROCORTISONE; INTERFERON-GAMMA; INTERLEUKIN-13; KERATINOCYTES; MICE; PSORIASIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VINCRISTINE;

EID: 84878613229     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1255-3     Document Type: Article

References (80)

1. Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353:1711-1723
2. Witchel SF, DeFranco DB (2006) Mechanisms of disease: regulation of glucocorticoid and receptor levels - impact on the metabolic syndrome. Nat Clin Pract Endocrinol Metab 2:621-631
3. Webster JI, Tonelli L, Sternberg EM (2002) Neuroendocrine regulation of immunity. Annu Rev Immunol 20:125-163
4. Budunova IV, Kowalczyk D, Perez P, Yao YJ, Jorcano JL, Slaga TJ (2003) Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis. Oncogene 22:3279-3287
5. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-873
6. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-509
7. Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352:1899-1912
8. Sevilla LM, Latorre V, Sanchis A, Perez P (2012) Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation. J Invest Dermatol. doi: 10.1038/jid.2012.281
9. Perez P (2011) Glucocorticoid receptors, epidermal homeostasis and hair follicle differentiation. Dermatoendocrinol 3:166-174
10. Yemelyanov A, Czwornog J, Chebotaev D, Karseladze A, Kulevitch E, Yang X, Budunova I (2007) Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 26:1885-1896
11. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435-2441
12. Galigniana MD, Housley PR, DeFranco DB, Pratt WB (1999) Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. J Biol Chem 274:16222-16227
13. Zhou J, Cidlowski JA (2005) The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70:407-417
14. DeFranco DB, Qi M, Borror KC, Garabedian MJ, Brautigan DL (1991) Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol Endocrinol 5:1215-1228
15. Madan AP, DeFranco DB (1993) Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc Natl Acad Sci USA 90:3588-3592
16. Beato M, Herrlich P, Schutz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
17. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83:835-839
18. Chrousos GP, Kino T (2005) Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005:pe48
19. Man XY, Yang XH, Cai SQ, Bu ZY, Zheng M (2008) Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. J Cell Mol Med 12:649-660
20. Man XY, Yang XH, Cai SQ, Yao YG, Zheng M (2006) Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med 12:127-136
21. Suzuki K, Bose P, Leong-Quong RY, Fujita DJ, Riabowol K (2010) REAP: a two-minute cell fractionation method. BMC Res Notes 3:294
22. Hilscherova K, Jones PD, Gracia T, Newsted JL, Zhang X, Sanderson JT, Yu RM, Wu RS, Giesy JP (2004) Assessment of the effects of chemicals on the expression of ten steroidogenic genes in the H295R cell line using real-time PCR. Toxicol Sci 81:78-89
23. Thiboutot D, Jabara S, McAllister JM, Sivarajah A, Gilliland K, Cong Z, Clawson G (2003) Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol 120:905-914
24. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146
25. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE (1999) Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 141:1054-1060
26. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111:1-6
27. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102:161-168
28. Detmar M (2004) Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis. J Invest Dermatol 122:xiv-xv
29. Young HS, Summers AM, Bhushan M, Brenchley PE, Griffiths CE (2004) Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 122:209-215
30. Abdallah MA, Abdel-Hamid MF, Kotb AM, Mabrouk EA (2009) Serum interferon-gamma is a psoriasis severity and prognostic marker. Cutis 84:163-168
31. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285:1733-1737
32. Otero MJ, Carrasco L (1984) Action of oligomycin on cultured mammalian cells. Permeabilization to translation inhibitors. Mol Cell Biochem 61:183-191
33. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182:5836-5845
34. Jordan MA, Himes RH, Wilson L (1985) Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res 45:2741-2747
35. Spokoini R, Kfir-Erenfeld S, Yefenof E, Sionov RV (2010) Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. Mol Endocrinol 24:1136-1150
36. Beurel E, Michalek SM, Jope RS (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31:24-31
37. Espinosa L, Ingles-Esteve J, Aguilera C, Bigas A (2003) Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem 278:32227-32235
38. Roberson ED, Bowcock AM (2010) Psoriasis genetics: breaking the barrier. Trends Genet 26:415-423
39. Bonifati C, Mussi A, Carducci M, Pittarello A, D'Auria L, Venuti A, Bagnato A, Salani D, Fazio M, Ameglio F (1998) Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol 78:22-26
40. Sato C, Tsuboi R, Shi CM, Rubin JS, Ogawa H (1995) Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. J Invest Dermatol 104:958-963
41. Sun LD, Cheng H, Wang ZX, Zhang AP, Wang PG, Xu JH, Zhu QX, Zhou HS, Ellinghaus E, Zhang FR, Pu XM, Yang XQ, Zhang JZ, Xu AE, Wu RN, Xu LM, Peng L, Helms CA, Ren YQ, Zhang C, Zhang SM, Nair RP, Wang HY, Lin GS, Stuart PE, Fan X, Chen G, Tejasvi T, Li P, Zhu J, Li ZM, Ge HM, Weichenthal M, Ye WZ, Shen SK, Yang BQ, Sun YY, Li SS, Lin Y, Jiang JH, Li CT, Chen RX, Cheng J, Jiang X, Zhang P, Song WM, Tang J, Zhang HQ, Sun L, Cui J, Zhang LJ, Tang B, Huang F, Qin Q, Pei XP, Zhou AM, Shao LM, Liu JL, Zhang FY, Du WD, Franke A, Bowcock AM, Elder JT, Liu JJ, Yang S, Zhang XJ (2010) Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet 42:1005-1009
42. King WJ, Greene GL (1984) Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307:745-747
43. Welshons WV, Krummel BM, Gorski J (1985) Nuclear localization of unoccupied receptors for glucocorticoids, estrogens, and progesterone in GH3 cells. Endocrinology 117:2140-2147
44. Kemppainen JA, Lane MV, Sar M, Wilson EM (1992) Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 267:968-974
45. Dauvois S, White R, Parker MG (1993) The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 106:1377-1388
46. Perrot-Applanat M, Logeat F, Groyer-Picard MT, Milgrom E (1985) Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology 116:1473-1484
47. Serres M, Viac J, Schmitt D (1996) Glucocorticoid receptor localization in human epidermal cells. Arch Dermatol Res 288:140-146
48. Chandler VL, Maler BA, Yamamoto KR (1983) DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell 33:489-499
49. Davies E, MacKenzie SM (2003) Extra-adrenal production of corticosteroids. Clin Exp Pharmacol Physiol 30:437-445
50. Noti M, Sidler D, Brunner T (2009) Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean? Semin Immunopathol 31:237-248
51. Noti M, Corazza N, Mueller C, Berger B, Brunner T (2010) TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis. J Exp Med 207:1057-1066
52. Mueller M, Atanasov A, Cima I, Corazza N, Schoonjans K, Brunner T (2007) Differential regulation of glucocorticoid synthesis in murine intestinal epithelial versus adrenocortical cell lines. Endocrinology 148:1445-1453
53. Nickoloff BJ, Xin H, Nestle FO, Qin JZ (2007) The cytokine and chemokine network in psoriasis. Clin Dermatol 25:568-573
54. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699-711
55. Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF (2009) Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci USA 106:21264-21269
56. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM et al (1993) p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833-839
57. Harrell JM, Murphy PJ, Morishima Y, Chen H, Mansfield JF, Galigniana MD, Pratt WB (2004) Evidence for glucocorticoid receptor transport on microtubules by dynein. J Biol Chem 279:54647-54654
58. Galigniana MD, Scruggs JL, Herrington J, Welsh MJ, Carter-Su C, Housley PR, Pratt WB (1998) Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol Endocrinol 12:1903-1913
59. Szapary D, Barber T, Dwyer NK, Blanchette-Mackie EJ, Simons SS Jr (1994) Microtubules are not required for glucocorticoid receptor-mediated gene induction. J Steroid Biochem Mol Biol 51:143-148
60. Vorgias CE, Perides GA, Traub P, Sekeris CE (1988) Colchicine, colcemide and cytochalasin B do not affect translocation of the glucocorticoid hormone-receptor in rat thymocytes or Ehrlich ascites cells. Biosci Rep 8:193-197
61. Reimer R, Helmbold H, Szalay B, Hagel C, Hohenberg H, Deppert W, Bohn W (2009) Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring. PLoS ONE 4:e6084
62. Glass CK, Saijo K (2010) Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol 10:365-376
63. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR (1992) Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1114:147-162
64. Ginger RS, Dalton EC, Ryves WJ, Fukuzawa M, Williams JG, Harwood AJ (2000) Glycogen synthase kinase-3 enhances nuclear export of a dictyostelium STAT protein. EMBO J 19:5483-5491
65. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930-1934
66. Rogatsky I, Waase CL, Garabedian MJ (1998) Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J Biol Chem 273:14315-14321
67. Nickoloff BJ (2007) Cracking the cytokine code in psoriasis. Nat Med 13:242-244
68. Blumberg H, Dinh H, Dean C Jr, Trueblood ES, Bailey K, Shows D, Bhagavathula N, Aslam MN, Varani J, Towne JE, Sims JE (2010) IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol 185:4354-4362
69. Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127:871-884
70. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok PY, Menter A, Lathrop GM, Wise CA, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41:199-204
71. Spadaro A, Rinaldi T, Riccieri V, Valesini G, Taccari E (2002) Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis. Ann Rheum Dis 61:174-176
72. Cancino-Diaz JC, Reyes-Maldonado E, Banuelos-Panuco CA, Jimenez-Zamudio L, Garcia-Latorre E, Leon-Dorantes G, Blancas-Gonzalez F, Paredes-Cabrera G, Cancino-Diaz ME (2002) Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein. J Invest Dermatol 119:1114-1120
73. Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461-467
74. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suarez-Farinas M, Fuentes-Duculan J, Novitskaya I, Khatcherian A, Bluth MJ, Lowes MA, Krueger JG (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183-3194
75. Guiochon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M, Milgrom E (1991) Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J 10:3851-3859
76. Sheu HM, Lee JY, Chai CY, Kuo KW (1997) Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br J Dermatol 136:884-890
77. du Vivier A, Phillips H, Hehir M (1982) Applications of glucocorticosteroids. The effects of twice-daily vs once-every-other-day applications on mouse epidermal cell DNA synthesis. Arch Dermatol 118:305-308
78. Carey W, Glazer S, Gottlieb AB, Lebwohl M, Leonardi C, Menter A, Papp K, Rundle AC, Toth D (2006) Relapse, rebound, and psoriasis adverse events: an advisory group report. J Am Acad Dermatol 54:S171-181
79. Davies L, Karthikeyan N, Lynch JT, Sial EA, Gkourtsa A, Demonacos C, Krstic-Demonacos M (2008) Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function. Mole Endocrinol 22:1331-1344
80. Vandevyver S, Dejager L, Van Bogaert T, Kleyman A, Liu Y, Tuckermann J, Libert C (2012) Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. J Clin Invest 122:2130-2140